Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Tanday

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
The Journal of Endocrinology|August 31, 2023
Sex-based impact of pancreatic islet stressors in GluCreERT2/Rosa26-eYFP miceNeil Tanday, Aimee Coulter-Parkhill, R Charlotte Moffett, et al.
Chronobiology International|May 17, 2024
TASK-3, two-pore potassium channels, contribute to circadian rhythms in the electrical properties of the suprachiasmatic nucleus and play a role in driving stable behavioural photic entrainmentAiste Steponenaite, Tatjana Lalic, Lynsey Atkinson, et al.
Biochemical Pharmacology|September 14, 2020
Antidiabetic drug therapy alleviates type 1 diabetes in mice by promoting pancreatic α-cell transdifferentiationDipak Sarnobat, Charlotte R Moffett, Neil Tanday, et al.
Diabetes/Metabolism Research and Reviews|December 1, 2018
Exendin-4(Lys<sup>27</sup> PAL)/gastrin/xenin-8-Gln: A novel acylated GLP-1/gastrin/xenin hybrid peptide that improves metabolic status in obese-diabetic (ob/ob) miceAnnie Hasib, Ming T Ng, Neil Tanday, et al.
Frontiers in Endocrinology|March 15, 2021
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic MiceRyan A Lafferty, Neil Tanday, R Charlotte Moffett, et al.
Peptides|November 19, 2019
Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic Glu<sup>CreERT2</sup>;ROSA26-eYFP miceDipak Sarnobat, R Charlotte Moffett, Victor A Gault, et al.
Molecular and Cellular Endocrinology|April 20, 2023
The glucagon receptor antagonist desHis<sup>1</sup>Pro<sup>4</sup>Glu<sup>9</sup>-glucagon(Lys<sup>12</sup>PAL) alters alpha-cell turnover and lineage in mice, but does not cause alpha-cell hyperplasiaRyan Lafferty, Neil Tanday, Vaibhav Dubey, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
The Journal of Endocrinology|August 31, 2023
Sex-based impact of pancreatic islet stressors in GluCreERT2/Rosa26-eYFP miceNeil Tanday, Aimee Coulter-Parkhill, R Charlotte Moffett, et al.
Chronobiology International|May 17, 2024
TASK-3, two-pore potassium channels, contribute to circadian rhythms in the electrical properties of the suprachiasmatic nucleus and play a role in driving stable behavioural photic entrainmentAiste Steponenaite, Tatjana Lalic, Lynsey Atkinson, et al.
Biochemical Pharmacology|September 14, 2020
Antidiabetic drug therapy alleviates type 1 diabetes in mice by promoting pancreatic α-cell transdifferentiationDipak Sarnobat, Charlotte R Moffett, Neil Tanday, et al.
Diabetes/Metabolism Research and Reviews|December 1, 2018
Exendin-4(Lys<sup>27</sup> PAL)/gastrin/xenin-8-Gln: A novel acylated GLP-1/gastrin/xenin hybrid peptide that improves metabolic status in obese-diabetic (ob/ob) miceAnnie Hasib, Ming T Ng, Neil Tanday, et al.
Frontiers in Endocrinology|March 15, 2021
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic MiceRyan A Lafferty, Neil Tanday, R Charlotte Moffett, et al.
Peptides|November 19, 2019
Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic Glu<sup>CreERT2</sup>;ROSA26-eYFP miceDipak Sarnobat, R Charlotte Moffett, Victor A Gault, et al.
Molecular and Cellular Endocrinology|April 20, 2023
The glucagon receptor antagonist desHis<sup>1</sup>Pro<sup>4</sup>Glu<sup>9</sup>-glucagon(Lys<sup>12</sup>PAL) alters alpha-cell turnover and lineage in mice, but does not cause alpha-cell hyperplasiaRyan Lafferty, Neil Tanday, Vaibhav Dubey, et al.
Pageof 3